Position in DNLI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$11,239
+$5,710 QoQ
Shares Held
437
+51.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#234
of 290 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROTHSCHILD INVESTMENT LLC holds $12,549,080 across 228 Biotechnology names. DNLI ranks #53 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,038 | $2,005,795 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
6,237 | $1,502,929 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
12,195 | $1,060,355 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
15,577 | $891,315 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,761 | $831,143 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
3,970 | $743,501 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,168 | $728,294 | |
| 8 | EXEL |
Exelixis, Inc.
|
11,735 | $638,501 |
All Filings in DNLI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,239 | 437 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,529 | 288 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,219 | 195 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,267 | 225 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,546 | 325 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $883 | 65 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $2,038 | 100 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $4,369 | 150 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,393 | 60 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $205 | 10 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||